Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular <i>BCR::ABL1</i> transcript in Chronic Myeloid Leukemia (CML)

Chronic myeloid leukemia (CML) persists due to leukemic stem cells, notably the CD26+ subset. We investigated correlations between circulating CD26+ leukemic stem cells (LSCs) and BCR::ABL1 transcripts in an extracellular vesicle-enriched secretome (EVES) from plasma samples of 44 CML patients. EVES were characterized and BCR::ABL1 quantified via digital PCR. We observed an inverse correlation between CD26+LSC counts and EVES BCR::ABL1 levels, especially in deep molecular responders (DMR). CD26+LSCs were elevated in patients in treatment-free remission (TFR), while EVES BCR::ABL1 levels were higher in those receiving therapy. These findings suggest distinct dynamics between LSC populations and vesicle-mediated transcript release, with potential implications for CML monitoring and prognosis.

Authors

Institutions

Publication Details

Journal
Stem Cells Translational Medicine
Published
2025-11-24
DOI
https://doi.org/10.1093/stcltm/szaf062
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML)

Claudia Ielo, Monica Bocchia, Simona Bernardi, Lucia Paolini et al.
Stem Cells Translational Medicine
Chronic Myeloid Leukemia Treatments
article

Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML)

Claudia Ielo, Monica Bocchia, Simona Bernardi, Lucia Paolini, Mirko Farina, Michele Malagola, Domenico Russo, Elisabetta Abruzzese, Anna Sicuranza, Valentina Mangolini, Alessandro Leoni, Paola Pacelli, Massimo Breccia, Alessia Cavalleri, Silvia Mutti, Teresa Miracapillo, Camilla Turriziani
article en

Abstract

Chronic myeloid leukemia (CML) persists due to leukemic stem cells, notably the CD26+ subset. We investigated correlations between circulating CD26+ leukemic stem cells (LSCs) and BCR::ABL1 transcripts in an extracellular vesicle-enriched secretome (EVES) from plasma samples of 44 CML patients. EVES were characterized and BCR::ABL1 quantified via digital PCR. We observed an inverse correlation between CD26+LSC counts and EVES BCR::ABL1 levels, especially in deep molecular responders (DMR). CD26+LSCs were elevated in patients in treatment-free remission (TFR), while EVES BCR::ABL1 levels were higher in those receiving therapy. These findings suggest distinct dynamics between LSC populations and vesicle-mediated transcript release, with potential implications for CML monitoring and prognosis.

Stem Cells Translational MedicineVol. 14(12)
Policlinico Umberto I (IT), Brescia University (US), Gene Therapy Laboratory (FR), Surgical Specialties (Canada) (CA), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Don Carlo Gnocchi Foundation (IT), Azienda Ospedaliera Universitaria Senese (IT), St. Eugenio Hospital (IT), University of Brescia (IT)
European Commission
Openalex Percentile: Top 53%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.